These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23548589)
1. Assessing community pharmacist engagement in a policing partnership strategy to reduce the illicit diversion of pseudoephedrine products. Webster JL Res Social Adm Pharm; 2013; 9(6):903-17. PubMed ID: 23548589 [TBL] [Abstract][Full Text] [Related]
2. Linked electronic medication systems in community pharmacies for preventing pseudoephedrine diversion: a review of international practice and analysis of results in Australia. Berbatis CG; Sunderland VB; Dhaliwal SS Drug Alcohol Rev; 2009 Nov; 28(6):586-91. PubMed ID: 19930010 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine. Chanda S; Sansgiry SS J Am Pharm Assoc (2003); 2008; 48(1):52-7. PubMed ID: 18192131 [TBL] [Abstract][Full Text] [Related]
4. The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals. Hughes CE; Moxham-Hall V; Ritter A; Weatherburn D; MacCoun R Int J Drug Policy; 2017 Mar; 41():91-100. PubMed ID: 28131615 [TBL] [Abstract][Full Text] [Related]
5. The impact of pseudoephedrine regulation at Australian pharmacies through Project Stop: A narrative review. Brookfield S; Gartner C Drug Alcohol Rev; 2024 Jan; 43(1):325-342. PubMed ID: 37963493 [TBL] [Abstract][Full Text] [Related]
6. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies. Mandt I; Horn AM; Ekedahl A; Granas AG Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324 [TBL] [Abstract][Full Text] [Related]
7. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey. Myers T; Cockerill R; Millson M; Rankin J; Worthington C AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241 [TBL] [Abstract][Full Text] [Related]
8. Kentucky pharmacists' opinions of the potential reclassification of pseudoephedrine as a legend drug. Monson KE; Freeman PR; Goodin AJ; Talbert J; Blumenschein K J Am Pharm Assoc (2003); 2014; 54(4):397-405. PubMed ID: 25063261 [TBL] [Abstract][Full Text] [Related]
9. Assessing health literacy practices in a community pharmacy environment: experiences using the AHRQ Pharmacy Health Literacy Assessment Tool. O'Neal KS; Crosby KM; Miller MJ; Murray KA; Condren ME Res Social Adm Pharm; 2013; 9(5):564-96. PubMed ID: 23267822 [TBL] [Abstract][Full Text] [Related]
10. Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling. Manning M; Wong GT; Ransley J; Smith C Int J Drug Policy; 2016 Jun; 32():85-92. PubMed ID: 27179610 [TBL] [Abstract][Full Text] [Related]
11. [IPADAM quali study. Intervention of the Pharmacist in the Issue of Self-medication: Experience of pharmacy team focus groups and patients' perceptions]. Savanovitch C; Bedhomme S; Van Lander A; Prunet-Spano C; Vennat B Ann Pharm Fr; 2018 Sep; 76(5):399-407. PubMed ID: 29801716 [TBL] [Abstract][Full Text] [Related]
13. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making. Paudyal V; Hansford D; Cunningham S; Stewart D Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of pseudoephedrine pharmacy sales before and after mandatory recording requirements in Western Australia: a case study. Hattingh HL; Varsani J; Kachouei LA; Parsons R Subst Abuse Treat Prev Policy; 2016 Aug; 11(1):30. PubMed ID: 27577258 [TBL] [Abstract][Full Text] [Related]
15. Community pharmacy in Australia: a health hub destination of the future. McMillan SS; Wheeler AJ; Sav A; King MA; Whitty JA; Kendall E; Kelly F Res Social Adm Pharm; 2013; 9(6):863-75. PubMed ID: 23218552 [TBL] [Abstract][Full Text] [Related]
16. Community pharmacists, Internet and social media: an empirical investigation. Shcherbakova N; Shepherd M Res Social Adm Pharm; 2014; 10(6):e75-e85. PubMed ID: 24388002 [TBL] [Abstract][Full Text] [Related]
17. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies. Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963 [TBL] [Abstract][Full Text] [Related]
18. Patients with epilepsy's perception on community pharmacist's current and potential role in their care. McAuley JW; Miller MA; Klatte E; Shneker BF Epilepsy Behav; 2009 Jan; 14(1):141-5. PubMed ID: 18984065 [TBL] [Abstract][Full Text] [Related]
19. An exploration of the utility of appraisals for the revalidation of pharmacy professionals in community pharmacy in Great Britain. Jee SD; Jacobs S; Schafheutle EI; Elvey R; Hassell K; Noyce PR Res Social Adm Pharm; 2013; 9(2):155-65. PubMed ID: 23517657 [TBL] [Abstract][Full Text] [Related]
20. A pharmacist model of perceived responsibility for drug therapy outcomes. Planas LG; Kimberlin CL; Segal R; Brushwood DB; Hepler CD; Schlenker BR Soc Sci Med; 2005 May; 60(10):2393-403. PubMed ID: 15748686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]